|
|
|
|
LEADER |
03177nam a2200565 4500 |
001 |
978-981-13-0529-0 |
003 |
DE-He213 |
005 |
20191022162022.0 |
007 |
cr nn 008mamaa |
008 |
180627s2018 si | s |||| 0|eng d |
020 |
|
|
|a 9789811305290
|9 978-981-13-0529-0
|
024 |
7 |
|
|a 10.1007/978-981-13-0529-0
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RB155-155.8
|
050 |
|
4 |
|a QH431
|
072 |
|
7 |
|a MFN
|2 bicssc
|
072 |
|
7 |
|a MED107000
|2 bisacsh
|
072 |
|
7 |
|a MFN
|2 thema
|
082 |
0 |
4 |
|a 611.01816
|2 23
|
082 |
0 |
4 |
|a 599.935
|2 23
|
245 |
1 |
0 |
|a Drosophila Models for Human Diseases
|h [electronic resource] /
|c edited by Masamitsu Yamaguchi.
|
250 |
|
|
|a 1st ed. 2018.
|
264 |
|
1 |
|a Singapore :
|b Springer Singapore :
|b Imprint: Springer,
|c 2018.
|
300 |
|
|
|a X, 308 p. 79 illus., 64 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|x 0065-2598 ;
|v 1076
|
520 |
|
|
|a Most biological pathways, physical and neurological properties are highly conserved between humans and Drosophila and nearly 75% of human disease-causing genes have a functional homologue in Drosophila. This volume provides recent advances in Drosophila models for various human diseases, with each chapter providing a review of studies involving Drosophila models, as well as detailed protocols commonly used in laboratories. Starting with a review of Drosophila's value as a highly tractable model organism for studying human diseases, subsequent chapters present Drosophila models for specific human diseases. The book provides a useful resource for all scientists who are starting to use the Drosophila model in their studies, and for researchers working in the pharmaceutical industry and using new screening models to develop new medicines for various diseases. .
|
650 |
|
0 |
|a Human genetics.
|
650 |
|
0 |
|a Cell biology.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
|
0 |
|a Metabolic diseases.
|
650 |
1 |
4 |
|a Human Genetics.
|0 http://scigraph.springernature.com/things/product-market-codes/B12008
|
650 |
2 |
4 |
|a Cell Biology.
|0 http://scigraph.springernature.com/things/product-market-codes/L16008
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|0 http://scigraph.springernature.com/things/product-market-codes/B21007
|
650 |
2 |
4 |
|a Neurosciences.
|0 http://scigraph.springernature.com/things/product-market-codes/B18006
|
650 |
2 |
4 |
|a Metabolic Diseases.
|0 http://scigraph.springernature.com/things/product-market-codes/H33118
|
700 |
1 |
|
|a Yamaguchi, Masamitsu.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9789811305283
|
776 |
0 |
8 |
|i Printed edition:
|z 9789811305306
|
776 |
0 |
8 |
|i Printed edition:
|z 9789811344428
|
830 |
|
0 |
|a Advances in Experimental Medicine and Biology,
|x 0065-2598 ;
|v 1076
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-13-0529-0
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SBL
|
950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|